487 related articles for article (PubMed ID: 27262672)
1. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
[TBL] [Abstract][Full Text] [Related]
2. The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling.
Minami E; Castellani C; Malchodi L; Deem J; Bertko K; Meznarich J; Dishmon M; Murry CE; Stempien-Otero A
J Mol Cell Cardiol; 2010 Sep; 49(3):516-24. PubMed ID: 20380835
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.
Meznarich J; Malchodi L; Helterline D; Ramsey SA; Bertko K; Plummer T; Plawman A; Gold E; Stempien-Otero A
PLoS One; 2013; 8(3):e57837. PubMed ID: 23536772
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction.
Shivshankar P; Halade GV; Calhoun C; Escobar GP; Mehr AJ; Jimenez F; Martinez C; Bhatnagar H; Mjaatvedt CH; Lindsey ML; Le Saux CJ
J Mol Cell Cardiol; 2014 Nov; 76():84-93. PubMed ID: 25128086
[TBL] [Abstract][Full Text] [Related]
7. Nrg1/ErbB signaling-mediated regulation of fibrosis after myocardial infarction.
Shiraishi M; Yamaguchi A; Suzuki K
FASEB J; 2022 Feb; 36(2):e22150. PubMed ID: 34997943
[TBL] [Abstract][Full Text] [Related]
8. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.
Jung M; Ma Y; Iyer RP; DeLeon-Pennell KY; Yabluchanskiy A; Garrett MR; Lindsey ML
Basic Res Cardiol; 2017 May; 112(3):33. PubMed ID: 28439731
[TBL] [Abstract][Full Text] [Related]
9. Regenerative cross talk between cardiac cells and macrophages.
Whitehead AJ; Engler AJ
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2211-H2221. PubMed ID: 33769920
[TBL] [Abstract][Full Text] [Related]
10. Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.
Schumacher D; Alampour-Rajabi S; Ponomariov V; Curaj A; Wu Z; Staudt M; Rusu M; Jankowski V; Marx N; Jankowski J; Brandenburg V; Liehn EA; Schuh A
Cardiovasc Pathol; 2019; 40():47-54. PubMed ID: 30852297
[TBL] [Abstract][Full Text] [Related]
11. CD226 deletion improves post-infarction healing via modulating macrophage polarization in mice.
Li J; Song Y; Jin JY; Li GH; Guo YZ; Yi HY; Zhang JR; Lu YJ; Zhang JL; Li CY; Gao C; Yang L; Fu F; Chen FL; Zhang SM; Jia M; Zheng GX; Pei JM; Chen LH
Theranostics; 2020; 10(5):2422-2435. PubMed ID: 32104514
[TBL] [Abstract][Full Text] [Related]
12. Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction.
Leblond AL; Klinkert K; Martin K; Turner EC; Kumar AH; Browne T; Caplice NM
PLoS One; 2015; 10(9):e0137515. PubMed ID: 26407006
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
14. Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype.
Hobby ARH; Berretta RM; Eaton DM; Kubo H; Feldsott E; Yang Y; Headrick AL; Koch KA; Rubino M; Kurian J; Khan M; Tan Y; Mohsin S; Gallucci S; McKinsey TA; Houser SR
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H684-H701. PubMed ID: 34415185
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice.
Ishikawa S; Noma T; Fu HY; Matsuzaki T; Ishizawa M; Ishikawa K; Murakami K; Nishimoto N; Nishiyama A; Minamino T
PLoS One; 2017; 12(11):e0187894. PubMed ID: 29121663
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
18. CXADR-like membrane protein protects against heart injury by preventing excessive pyroptosis after myocardial infarction.
Han X; Zhao ZA; Yan S; Lei W; Wu H; Lu XA; Chen Y; Li J; Wang Y; Yu M; Wang Y; Zheng Y; Wang H; Shen Z; Hu S
J Cell Mol Med; 2020 Dec; 24(23):13775-13788. PubMed ID: 33084169
[TBL] [Abstract][Full Text] [Related]
19. Sema3A promotes the resolution of cardiac inflammation after myocardial infarction.
Rienks M; Carai P; Bitsch N; Schellings M; Vanhaverbeke M; Verjans J; Cuijpers I; Heymans S; Papageorgiou A
Basic Res Cardiol; 2017 Jul; 112(4):42. PubMed ID: 28540528
[TBL] [Abstract][Full Text] [Related]
20. The fibrogenic actions of lung fibroblast-derived urokinase: a potential drug target in IPF.
Schuliga M; Jaffar J; Harris T; Knight DA; Westall G; Stewart AG
Sci Rep; 2017 Jan; 7():41770. PubMed ID: 28139758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
